BridgeBio

formerly BridgeBio PharmaIPO

BridgeBio is a biotech company in San Francisco Bay Area, United States, founded in 2014. It has raised $2.7B across 6 rounds, most recently a $1.0B Growth Equity in July 2026.

We exist to bring meaningful medicines to patients quickly & safely.

Employees
201–500
Founded
2014
Business Model
Other
Total Funding
$2.7B
Last Round
$1.0B Growth EquityJul 2026
Rounds
6
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 6 funding rounds and 13 investors for this company. The full record is or through the API.

About

BridgeBio is a biotechnology company designing transformative medicines for patients with genetic diseases and cancers with clear genetic drivers. It has a late-stage investigational pipeline including Acoramidis for ATTRv, BBP-418 for LGMD2I/R9, Encaleret for ADH1 and hypoparathyroidism, Infigratinib for achondroplasia and hypochondroplasia, and BBP-812 for Canavan Disease.

Summary

It lists 201–500 employees. It has raised $2.7B in total across 6 rounds, most recently a $1.0B Growth Equity round in Jul 2026. Investors include Blue Owl Capital, KKR and Viking Global.

Tech & App Stack

11 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

Data from Indexed.vcUpdated
Growth EquityGrowth EquityJul 2026
$1.0B

Sign up to see all 9 events

Funding: Series C through Growth Equity. Amounts, valuations, and investors where available.

Investors

Similar Companies

Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Calico

Calico researches human aging using advanced technologies and model systems, applying that knowle...

South San Francisco, United States201–500Biotech, Healthcare
Corporate RoundTotal funding$2.3BJun 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020
CertaraIPO

Global biosimulation software and services company accelerating drug development for 2,000+ bioph...

Radnor, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$1.3BDec 2022
Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

BridgeBio on Indexed.vc
<a href="https://indexed.vc/companies/bridgebio"><img src="https://indexed.vc/api/badge/company/bridgebio" alt="BridgeBio on Indexed.vc" width="260" height="76" /></a>